1403-A PTPN2/N1 inhibitor ABBV-CLS-484 unleashes potent anti-tumor immunity
Wei Qiu,Qi Sun,Yi Yang,Chirag Patel,Meng Sun,Yue Liu,Kyle Halliwill,Sarah Kim,Rebecca Mathew,Jennifer M Frost,Jennifer A Roth,Domenick Kennedy,Robert T Manguso,Kathleen B Yates,Hakimeh Ebrahimi-Nik,Christina K Baumgartner,Arvin Iracheta-Vellve,Keith M Hamel, Kira Olander, Thomas GR Davis,Kathleen A McGuire, Geoff T Halvorsen, Omar I Avila, Ashwin V Kammula,Audrey J Muscato,Prasanthi Geda, Kelly Klinge,Zhaoming Xiong,Ryan Duggan, Liang Mu,Mitchell D Yeary,James C Patti, Tyler M Balon,Carey Backus,Angeline Chen,Kenton Longenecker,Joseph Klahn, Cara Hrusch,Navasona Krishnan,Charles W Hutchins, Jacqueline Aguado,Marinka Bulic,Payal Tiwari,Kayla J Colvin, Cun Lan Chuong,Ian C Kohnle, Matthew G Rees,Andrew Boghossian,Melissa Ronan,Meng-Ju Wu,Debattama R Sen,Gabriel K Griffin, Nabeel El-Bardeesy,Patricia Trusk, Joshua H Decker,Stacey Fossey, Marcia N Paddock,Elliot P Farney,Clay Beauregard,Philip R Kym Journal for ImmunoTherapy of Cancer（2023）
AI 理解论文
溯源树
样例
